Stopping tirzepatide cold turkey and stopping semaglutide abruptly both carry significant risks including appetite rebound, gastrointestinal changes, mood shifts, and rapid weight regain
Meanwhile, the thyroid hormone conversion boost further accelerates fat metabolism
These benefits were associated with a rebalancing of the cytokine milieureducing pro-inflammatory IL-6, IL-1, and TNF- while elevating anti-inflammatory TGF-1mediated by the suppression of the MAPK signaling pathway [76]
They are reflections of meaning
This strategic move aligns with the potential of GLP-1 agonists in weight loss, underscored by the recent FDA approval of Zepbound for obesity treatment
One key way GLP-1 supports weight management is by enhancing feelings of fullness after meals